XSpray Pharma AB (OSTO:XSPRAY) 3-Year EBITDA Growth Rate : -36.60% (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is XSpray Pharma AB 3-Year EBITDA Growth Rate?

XSpray Pharma AB's EBITDA per Share for the three months ended in Mar. 2024 was kr-2.08.

During the past 3 years, the average EBITDA Per Share Growth Rate was -36.60% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was -36.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 9 years, the highest 3-Year average EBITDA Per Share Growth Rate of XSpray Pharma AB was -13.20% per year. The lowest was -112.10% per year. And the median was -33.75% per year.

Competitive Comparison of XSpray Pharma AB's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, XSpray Pharma AB's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

XSpray Pharma AB's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, XSpray Pharma AB's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where XSpray Pharma AB's 3-Year EBITDA Growth Rate falls into.

XSpray Pharma AB 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

XSpray Pharma AB (OSTO:XSPRAY) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

XSpray Pharma AB 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of XSpray Pharma AB's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

XSpray Pharma AB (OSTO:XSPRAY) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » XSpray Pharma AB (OSTO:XSPRAY) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

0GHZ:UK 6XP:Germany

Address

Rasundavagen 12, Solna, SWE, 169 67

Website

https://www.xspraypharma.com

XSpray Pharma AB is a product development company with several product candidates in clinical development. It develops, sells and licenses generic versions of marketed cancer drugs, protein kinase inhibitors. The company primarily develops protein kinase inhibitors (PKI) are the largest segment within cancer drugs targeted for cancer treatment.

XSpray Pharma AB (OSTO:XSPRAY) Headlines

No Headlines